S&P Futures
6,026.25 -12.00 (-0.20%) Dow Futures
44,903.00 -48.00 (-0.11%) Nasdaq Futures
20,912.50 -81.00 (-0.39%) Russell 2000 Futures
2,436.80 +4.40 (+0.18%) Crude Oil
69.20 +0.43 (+0.63%) Gold
2,674.60 +28.30 (+1.07%)
Esperion Therapeutics, Inc. (ESPR)
After hours:
| Previous Close | 2.5700 |
| Open | 2.5200 |
| Bid | 2.5400 x 1500 |
| Ask | 2.5800 x 3100 |
| Day's Range | 2.5106 - 2.6100 |
| 52 Week Range | 1.1900 - 3.4000 |
| Volume | |
| Avg. Volume | 3,811,866 |
| Market Cap | 506.38M |
| Beta (5Y Monthly) | 0.95 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.6700 |
| Earnings Date | Feb 25, 2025 - Mar 03, 2025 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.51 |
GlobeNewswireOtsuka Submits New Drug Application in Japan for Bempedoic Acid in the Treatment of Hypercholesterolemia
ANN ARBOR, Mich., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that Otsuka Pharmaceutical Co., Ltd. (Otsuka) has submitted a New Drug Application (NDA) to the Japanese Ministry of Health, Labour and Welfare for the manufacture and sale of bempedoic acid in Japan for the treatment of hypercholesterolemia and familial hypercholesterolemia. Bempedoic acid has a novel mechanism of action that inhibits a cholesterol synthesis pathway by acting on ATP (adenosine triphospha
- GlobeNewswire
Esperion to Participate in Upcoming Piper Sandler 36th Annual Healthcare Conference
ANN ARBOR, Mich., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the webcasted 2024 Piper Sandler 36th Annual Healthcare Conference on Thursday, December 5, 2024, at 12:30 p.m. ET. The live webcast can be accessed on the investor and media section of the Esperion website. Access to the webcast replay will be available approximately two hours after the completion of the call and will be archived on the Company’s website for appr
